Thomas Z. Rohan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas Z. Rohan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Henry Y. Yang
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
2 shared publications - Jaanvi Mehta
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA, jefferson.edu
2 shared publications - Jenna L. Mandel
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA, jefferson.edu
2 shared publications - Lauren Banner
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
2 shared publications - Neda Nikbakht
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA; Departments of Dermatology, Hematology, and Medical Oncology, Emory University, Atlanta, GA
2 shared publications - Sherry Yang
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania
2 shared publications
Latest Publications
- Open Access
Increased Risk of Portal Hypertension-Related Complications in Those with History of Bariatric Surgery and Alcohol-Associated Hepatitis
Background and Objectives: Bariatric surgery is a highly effective obesity treatment, yet it may predispose individuals to alcohol-related liver injury. While altered ethanol metabolism following procedures like Roux-en-Y gastric bypass (RYGB) is well described, the long-term hepatic consequences, particularly the risk of portal hypertension in patients who develop alcohol-related hepatitis (AH,) remain poorly defined. Methods: Using the TriNetX US Collaborative Network, we identified adult patients diagnosed with AH or alcohol-related cirrhosis. We compared outcomes between patients with a history of RYGB or sleeve gastrectomy (SG) who subsequently developed AH (Bariatric+AH group) and those with AH and no history of bariatric surgery (AH-only group). Propensity score matching was performed on over 44 demographic, clinical, and laboratory variables. Cox proportional hazards models and Kaplan-Meier survival curves were used to estimate the risk of clinically significant portal hypertension (PH) events, liver transplantation, and all-cause mortality at three-, five-, and seven-year follow-ups. Results: After matching, 772 patients were included in each cohort. At 7 years post-index event, the Bariatric + AH group exhibited a significantly higher risk of PH-related complications compared to the AH-only group (HR 1.519; 95% CI, 1.15–2.005; p = 0.003). No significant differences were observed in liver transplantation (HR 1.412; 95% CI, 0.850–2.346; p = 0.181) or all-cause mortality (HR 1.085; 95% CI, 0.904–1.303; p = 0.381). These findings were consistent across all follow-up intervals. Conclusion: Bariatric surgery is associated with an increased long-term risk of portal hypertension in patients who develop alcohol-related hepatitis despite similar mortality and transplantation rates. These findings underscore the need for targeted postoperative counseling, liver-focused surveillance strategies, and integration of hepatologic risk assessment into metabolic surgery care pathways.
Open AccessIncreased Risk of Portal Hypertension-Related Complications in Those with History of Bariatric Surgery and Alcohol-Associated Hepatitis
Background and Objectives: Bariatric surgery is a highly effective obesity treatment, yet it may predispose individuals to alcohol-related liver injury. While altered ethanol metabolism following procedures like Roux-en-Y gastric bypass (RYGB) is well described, the long-term hepatic consequences, particularly the risk of portal hypertension in patients who develop alcohol-related hepatitis (AH,) remain poorly defined. Methods: Using the TriNetX US Collaborative Network, we identified adult patients diagnosed with AH or alcohol-related cirrhosis. We compared outcomes between patients with a history of RYGB or sleeve gastrectomy (SG) who subsequently developed AH (Bariatric+AH group) and those with AH and no history of bariatric surgery (AH-only group). Propensity score matching was performed on over 44 demographic, clinical, and laboratory variables. Cox proportional hazards models and Kaplan-Meier survival curves were used to estimate the risk of clinically significant portal hypertension (PH) events, liver transplantation, and all-cause mortality at three-, five-, and seven-year follow-ups. Results: After matching, 772 patients were included in each cohort. At 7 years post-index event, the Bariatric + AH group exhibited a significantly higher risk of PH-related complications compared to the AH-only group (HR 1.519; 95% CI, 1.15–2.005; p = 0.003). No significant differences were observed in liver transplantation (HR 1.412; 95% CI, 0.850–2.346; p = 0.181) or all-cause mortality (HR 1.085; 95% CI, 0.904–1.303; p = 0.381). These findings were consistent across all follow-up intervals. Conclusion: Bariatric surgery is associated with an increased long-term risk of portal hypertension in patients who develop alcohol-related hepatitis despite similar mortality and transplantation rates. These findings underscore the need for targeted postoperative counseling, liver-focused surveillance strategies, and integration of hepatologic risk assessment into metabolic surgery care pathways.
- Open Access
- 9 September 2025
- Published by Elsevier in JID Innovations
- Vol. 6 (1)
Increased Risk of Postoperative Complications in Patients with Hypertension Undergoing Mohs Micrographic Surgery
- 9 September 2025
- Published by Elsevier in JID Innovations
- Vol. 6 (1)
Open AccessIncreased Risk of Postoperative Complications in Patients with Hypertension Undergoing Mohs Micrographic Surgery
- Open Access
- 9 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1110
Hidradenitis Suppurativa Is Associated with an Increased Risk of Adverse Cardiac Events and All-Cause Mortality
Background: Hidradenitis suppurativa (HS) has been previously associated with greater rates of major adverse cardiac events (MACEs) compared to the general population. This study aims to better elucidate the association between HS, MACEs, and other cardiovascular diseases. Methods: We utilized TriNetX, a global database of electronic health records, to conduct a retrospective cohort study. HS patients were matched on demographic and cardiovascular disease risk factors to both healthy and psoriasis groups as controls. Results: After adjusting for cardiovascular disease risk factors, HS patients had a relative risk (RR) (95% CI) of 2.06 (1.83–2.32) for myocardial infarction, 1.62 (1.44–1.82) for ischemic stroke, 2.21 (2.04–2.40) for heart failure, 1.95 (1.84–2.07) for MACEs, and 2.57 (2.34–2.83) for all-cause mortality compared to healthy controls. When comparing HS patients to matched psoriasis controls, HS patients had an RR of 1.31 (1.17–1.47) for myocardial infarction, 1.04 (0.93–1.16) for ischemic stroke, 1.24 (1.15–1.34) for heart failure, 1.16 (1.09–1.22) for MACEs, and 1.38 (1.27–1.5) for all-cause mortality. Herein, we demonstrate that patients with HS have increased rates of all cardiovascular diseases investigated when compared to healthy and psoriasis controls, even after adjusting for cardiovascular disease risk factors. Conclusions: These findings highlight the potential benefit in screening for and managing modifiable cardiovascular risk factors in HS patients.
- 9 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1110
Open AccessHidradenitis Suppurativa Is Associated with an Increased Risk of Adverse Cardiac Events and All-Cause Mortality
Background: Hidradenitis suppurativa (HS) has been previously associated with greater rates of major adverse cardiac events (MACEs) compared to the general population. This study aims to better elucidate the association between HS, MACEs, and other cardiovascular diseases. Methods: We utilized TriNetX, a global database of electronic health records, to conduct a retrospective cohort study. HS patients were matched on demographic and cardiovascular disease risk factors to both healthy and psoriasis groups as controls. Results: After adjusting for cardiovascular disease risk factors, HS patients had a relative risk (RR) (95% CI) of 2.06 (1.83–2.32) for myocardial infarction, 1.62 (1.44–1.82) for ischemic stroke, 2.21 (2.04–2.40) for heart failure, 1.95 (1.84–2.07) for MACEs, and 2.57 (2.34–2.83) for all-cause mortality compared to healthy controls. When comparing HS patients to matched psoriasis controls, HS patients had an RR of 1.31 (1.17–1.47) for myocardial infarction, 1.04 (0.93–1.16) for ischemic stroke, 1.24 (1.15–1.34) for heart failure, 1.16 (1.09–1.22) for MACEs, and 1.38 (1.27–1.5) for all-cause mortality. Herein, we demonstrate that patients with HS have increased rates of all cardiovascular diseases investigated when compared to healthy and psoriasis controls, even after adjusting for cardiovascular disease risk factors. Conclusions: These findings highlight the potential benefit in screening for and managing modifiable cardiovascular risk factors in HS patients.
- 16 November 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-2
Rates of sepsis among patients hospitalized for hidradenitis suppurativa
- 16 November 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-2
Rates of sepsis among patients hospitalized for hidradenitis suppurativa
- Open Access
- 6 November 2024
- Published by Elsevier in JID Innovations
- Vol. 5 (1) , 100323
Identifying Subsets of Cancer Patients with an Increased Risk of Developing Cutaneous Melanoma: A Surveillance, Epidemiology, and End Results–Based Analysis
- 6 November 2024
- Published by Elsevier in JID Innovations
- Vol. 5 (1) , 100323
Open AccessIdentifying Subsets of Cancer Patients with an Increased Risk of Developing Cutaneous Melanoma: A Surveillance, Epidemiology, and End Results–Based Analysis